Close
Help




JOURNAL

Clinical Medicine Insights: Women's Health

Safety, Efficacy, and Patient Acceptability of the Copper T-380A Intrauterine Contraceptive Device

Submit a Paper


Clinical Medicine Insights: Women's Health

Review

Published on 31 Mar 2011

DOI: 10.4137/CMWH.S5332


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Women's Health

Abstract

The ParaGard Copper T 380A intrauterine device (CuT380A) provides reversible contraception that is as effective as sterilization for up to 20 years. The CuT380A is a mainstream, first-line contraceptive option for most healthy women, including nulligravid women, as well as many women who have serious medical problems. Because it is the most cost-effective method of birth control, the CuT380A is the preferred IUD, except for women who desire lighter or no menstrual blood loss. Surveys reveal that 95% of US CuT380A users are “very” or “somewhat” satisfied with their method. This article describes current candidates for IUD use, discusses the mechanisms of action of the CuT380A, provides guidance to reduce barriers to IUD access, suggests counseling points for patients, and outlines techniques to reduce the risks and side effects that can be associated with use of the CuT380A.



Downloads

PDF  (647.64 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Libertas Academica
I must say publishing with Evolutionary Bioinformatics was a great and partially unexpected experience.  It allowed me to understand the name 'Libertas Academica' is not just a name but a real issue.  The reviewers offered us stringent, rigorous but totally unprejudiced comments, the editor supported us and the paper visibility was very good.  Thank you again.
Dr Alessandro Giuliani (Istituto Superiore di Sanità, Roma, Italy)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube